Department of Medical Research, Holstebro Hospital, Holstebro, Denmark.
BMC Nephrol. 2012 Mar 27;13:15. doi: 10.1186/1471-2369-13-15.
Dysregulation of the expression/shuttling of the aquaporin-2 water channel (AQP2) and the epithelial sodium channel (ENaC) in renal collecting duct principal cells has been found in animal models of hypertension. We tested whether a similar dysregulation exists in essential hypertension.
We measured urinary excretion of AQP2 and ENaC β-subunit corrected for creatinine (u-AQP2(CR), u-ENaC(β-CR)), prostaglandin E2 (u-PGE2) and cyclic AMP (u-cAMP), fractional sodium excretion (FE(Na)), free water clearance (C(H2O)), as well as plasma concentrations of vasopressin (AVP), renin (PRC), angiotensin II (Ang II), aldosterone (Aldo), and atrial and brain natriuretic peptide (ANP, BNP) in 21 patients with essential hypertension and 20 normotensive controls during 24-h urine collection (baseline), and after hypertonic saline infusion on a 4-day high sodium (HS) diet (300 mmol sodium/day) and a 4-day low sodium (LS) diet (30 mmol sodium/day).
At baseline, no differences in u-AQP2(CR) or u-ENaC(β-CR) were measured between patients and controls. U-AQP2(CR) increased significantly more after saline in patients than controls, whereas u-ENaC(β-CR) increased similarly. The saline caused exaggerated natriuretic increases in patients during HS intake. Neither baseline levels of u-PGE2, u-cAMP, AVP, PRC, Ang II, Aldo, ANP, and BNP nor changes after saline could explain the abnormal u-AQP2(CR) response.
No differences were found in u-AQP2(CR) and u-ENaC(β-CR) between patients and controls at baseline. However, in response to saline, u-AQP2(CR) was abnormally increased in patients, whereas the u-ENaC(β-CR) response was normal. The mechanism behind the abnormal AQP2 regulation is not clarified, but it does not seem to be AVP-dependent. Clinicaltrial.gov identifier: NCT00345124.
在高血压动物模型中,已经发现肾集合管主细胞中水通道蛋白-2(AQP2)和上皮钠通道(ENaC)的表达/穿梭失调。我们测试了这种类似的失调是否存在于原发性高血压中。
我们测量了 21 例原发性高血压患者和 20 例正常血压对照者 24 小时尿液收集期间(基线)以及高盐(HS)饮食(300mmol 钠/天)和低盐(LS)饮食(30mmol 钠/天)4 天后,尿 AQP2 和 ENaCβ-亚基(u-AQP2(CR),u-ENaC(β-CR))、前列腺素 E2(u-PGE2)和环磷酸腺苷(u-cAMP)、钠排泄分数(FE(Na))、自由水清除率(C(H2O))以及血管加压素(AVP)、肾素(PRC)、血管紧张素 II(Ang II)、醛固酮(Aldo)、心房利钠肽(ANP)和脑利钠肽(BNP)的血浆浓度。
基线时,患者和对照组之间的 u-AQP2(CR)或 u-ENaC(β-CR)无差异。盐水后患者的 u-AQP2(CR)增加明显多于对照组,而 u-ENaC(β-CR)增加相似。在 HS 摄入期间,盐水引起患者的利尿作用明显增加。基线时 u-PGE2、u-cAMP、AVP、PRC、Ang II、Aldo、ANP 和 BNP 的水平以及盐水后的变化均不能解释 u-AQP2(CR)反应异常。
基线时,患者和对照组之间的 u-AQP2(CR)和 u-ENaC(β-CR)无差异。然而,在盐水反应中,患者的 u-AQP2(CR)异常增加,而 u-ENaC(β-CR)反应正常。AQP2 调节异常的机制尚不清楚,但似乎与 AVP 无关。Clinicaltrial.gov 标识符:NCT00345124。